News
-
-
May 2023BioView and ANGLE have opened up “a major market opportunity” with breast cancer partnership. Watch the interview with Dr. Alan Schwebel, BioView’s CEO. Copy
-
April 2023ANGLE Announces Partnership With BioView to develop a liquid biopsy circulating tumor cell (CTC) HER2 assay for breast cancer
Angle and Bioview present combined solution for circulating tumor cell detection and analysis
-
July 2021Capio Biosciences and BioView Ltd Announce Collaboration to Develop Integrated Workflow for Sample to Answer Assay of Circulating Tumor Cells
Capio Biosciences and BioView agreed to launch a joint study to evaluate the performance of an integrated solution of clinical utility making use of Capio’s CapioCyte and BioView’s DeNovo systems for the detection and characterization of tumor cells originating from prostate cancer stained with specific tumor related biomarkers.
-
December 2020BioView and INL spin-off RUBYnanomed start collaboration to improve cancer diagnostics
The collaboration combines RUBYnanomed’s technology, the RUBYchip™ that provides highly efficient isolation of CTCs from blood samples of cancer patients, and BioView’s Duet imaging and analysis system, which streamlines the otherwise challenging process of CTC detection and analysis.
-
December 2020BioView and INL spin-off RUBYnanomed start collaboration to improve cancer diagnostics
The collaboration combines RUBYnanomed’s technology, the RUBYchip™ that provides highly efficient isolation of CTCs from blood samples of cancer patients, and BioView’s Duet imaging and analysis system, which streamlines the otherwise challenging process of CTC detection and analysis.
-
June 2020Abbott Molecular presents a lung cancer multiplex fast FISH assay using BioView image analysis system
A newly developed 6-color FISH assay allows simultaneous detection of three lung cancer related genomic abnormalities using only one specimen slide.
-
May 2020Innovative CTC FISH test for early diagnosis of lung cancer introduced by Sanmed Biotech
Innovative emerging technology for auxiliary diagnosis of benign and malignant lung nodules
-
February 2020Angle plc and BioView Press Release
Angle and Bioview present combined solution for circulating tumor cell detection and analysis
-
February 2020Angle plc and BioView joint CTC presentation at the upcoming 2020 Tri-Con meeting
Angle plc and BioView will present results of a collaborative efforts that utilizes Angle’s CTC harvesting with BioView’s automated CTC cell imaging and analysis scanner
-
December 2019BioView’s Karyotype application is now powered by the latest technological breakthroughs in AI and Deep Learning
BioView is proud to announce it’s automated metaphase finding as well as G and R band chromosomes classification are now powered by the latest technological breakthroughs in AI and Deep Learning.
-
October 2018Abnova & BioView Successfully Developed All-in-One Imaging System and Artificial Intelligence (AI) Solution for Identification of Circulating Tumor and Fetal Cells (CTCs and CFCs) Copy
BioView and Abnova are happy to announce today the launch of an integrated all-in-one imaging system with artificial intelligence (AI) solution for the identification of circulating tumor cells (CTCs) and circulating fetal cells (CFCs)
-
March 2018Vortex Biosciences and BioView Announce Collaboration to Develop Integrated Workflow for Clinical Biomarker Identification on Circulating Tumor Cells Copy
BioView and Vortex Biosciences are happy to announce a collaboration to develop an integrated workflow for identifying clinical biomarkers on CTCs
-
November 2016AMP Conference workshop – Utilization of Innovative Web Based FISH Review and Analysis Solution in Daily Clinical Practice
-
March 2016BioView receives TFDA regulatory clearance to market its products in Taiwan Copy
BioView is happy to announce that it has received the QSD certificate from Taiwanese FDA
-
December 2015Distribution agreement for BioView’s early detection Lung Cancer Test was signed in Australia and New-Zealand
BioView is happy to announce that it has signed an agreement with Diagnostic Solutions (Australia) for the marketing of the LCD test developed for Australia and New-Zealand.
-
November 2015BioView Receives Chinese FDA Clearance for DUET Automated FISH Imaging Systems
BioView announced today that it has received clearance from the Food and Drug Administration of the Republic of China (CFDA) for its DUET Automated FISH Scanning and Analysis systems.
-
September 2015BioView non-invasive sputum FISH test receives CE Mark
BioView is pleased to announce that the DUET system and the company’s proprietary non-invasive sputum FISH probed based test, assisting in early detection of Lung Cancer is compliant to the CE directive 98/79/EEC concerning in vitro diagnostic medical devices. BioView Lung Cancer test CE Marking, enables the product to be marketed …
-
August 2015Big tender award in Asia Pacific
BioView is pleased to announce that it has received an order from its Worldwide Distributor, Abbott Molecular, for 7 Allegro Plus scanning instruments for 7 Hospitals in a Country in Asia Pacific. This order was received subsequent to Abbott Molecular being awarded a tender from a large Hospital…
-
May 2014BioView receives FDA clearance for ALK FISH application
BioView is pleased to announce that the United States Food and Drug Administration (FDA) cleared for marketing in the United States…
-
September 2014BioView receives Australian TGA regulatory approval
BioView is pleased to announce that the DUET system received the Australian TGA regulatory approval.
The Duet™ system is an automated scanning microscope and image analysis system. It is intended for in-vitro diagnosis use as an aiding tool in the detection, classification and counting of cells of interests based on particular color, intensity, size, pattern and shape. -
August 2014Development agreement signed
BioView Ltd. and Abbott have entered into a joint development agreement. Under terms of the agreement, Abbott plans to develop FISH probes for Research Use Only (RUO) and in-vitro diagnostic (IVD) purposes worldwide and BioView will develop software and software applications…
-
March 2014BioView receives Korea FDA approval
BioView is pleased to announce the receipt of Korean FDA approval for marketing of Bioview’s scanning systems in Korea. Bioview’s cell imaging systems for analysis of cells stained by morphological, immunohistochemical and FISH markers allows automatic scanning…